Big Data Marketing Pharma Companies Production 
Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? His work provides insight into AI and big data in relation to pharma and drug discovery– now and in the future. “AI Up front collection and controlling your data! His advice?
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. Complex generics comprise a diverse range of products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
FEBRUARY 6, 2024
Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. Universities are also using these digital technologies to advance their research.
pharmaphorum
JULY 14, 2022
A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.
Pharmaceutical Technology
NOVEMBER 9, 2022
According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. The legacy of this disruption has been a rethink in the way pharma companies do business.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
pharmaphorum
FEBRUARY 16, 2021
COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. . The R&D focus began to shift, and so did the marketing.
Expert insights. Personalized for you.
52 
Let's personalize your content